A survey of pharmacy and therapeutic committees across Canada : Scope and responsibilities

Canadian Journal of Clinical Pharmacology

Volumn 16, Issue 1, 2009, Pages

  Mittmann, Nicole ^a   Knowles, Sandra ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Canada; Formulary decision making; Pharmacy and therapeutic committees; Survey

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; CANADA; DRUG FORMULARY; DRUG MONITORING; DRUG SAFETY; ECONOMIC ASPECT; NURSE; NUTRITION; PATIENT SAFETY; PHARMACIST; PHARMACY AND THERAPEUTICS COMMITTEE;

EID: 63449111931     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Tyler LS, Cole SW, May JR, et al. ASHP guidelines on the pharmacy and therapeutics committee and the formulary system. Am J Health Syst Pharm 2008;65:1272-83.
2. Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2004. Am J Health Syst Pharm 2005;62(4):378-90.
3. Mannebach MA, Ascione FJ, Gaither CA, Bagozzi RP, Cohen IA, Ryan ML. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals. Am J Health Syst Pharm 1999;56(7):622-8.
4. Wang Z, Salmon JW, Walton SM. Cost-effectiveness analysis and the formulary decision-making process. J Manag Care Pharm 2004;10(1):48-59.
5. Shalansky SJ, Virk R, Ackman M, et al. Access to new cardiovascular therapies in Canadian hospitals: a national survey of the formulary process. Can J Cardiol 2003;19(2):173-9.
6. Balu S, O'Connor P, Vogenberg FR. Contemporary issues affecting P&T committees. Part 2: Beyond managed care. P&T 2004;29(12):780-3.
7. Wade WE, Spruill WJ, Taylor AT, Longe RL, Hawkins DW. The expanding role of pharmacy and therapeutics committees. The 1990s and beyond. Pharmacoeconomics 1996;10(2):123-8.
8. Description and Analysis of the VA National Formulary. Washington: National Academy Press, 2000.
9. Tan EL, Day RO, Brien JA. Prioritising drug and therapeutics committee (DTC) decisions: a national survey. Pharm World Sci 2007;29:90-6.
10. Nichol MB, Knight TK, Epstein J, Honda DH, Tretiak R. Opinions regarding the Academy of Managed Care Pharmacy dossier submission guidelines: Results of a small survey of managed care organizations and pharmaceutical manufacturers. J Manag Care Pharm 2007;13(4):360-71.
11. Odedina FT, Sullivan J, Nash R, Clemmons CD. Use of pharmacoeconomic data in making hospital formulary decisions. Am J Health Syst Pharm 200;59:1441-4.